Featured Research

from universities, journals, and other organizations

Antigen-encapsulated chitosan particles improve immune response

Date:
March 4, 2013
Source:
University of Arkansas, Fayetteville
Summary:
Biomedical engineering researchers have encapsulated two types of protein antigens in chitosan and demonstrated that the combined material enables or improves three important immune responses.

Bhanu Koppolu uses a flow cytometer to identify changes in immune cell populations.
Credit: Russell Cothren, University of Arkansas

Biomedical engineering researchers at the University of Arkansas have encapsulated two types of protein antigens in chitosan and demonstrated that the combined material enables or improves three important immune responses.

The researchers -- Bhanu Koppolu, a doctoral student and senior research assistant, and David Zaharoff, assistant professor of biomedical engineering -- have worked with chitosan for many years and continue to demonstrate its effectiveness as potential biomaterial for the targeted delivery of vaccines and immunotherapy.

"A great deal of effort has been spent developing delivery systems capable of enhancing vaccine responses with specific antigens," Koppolu said. "We believe we have developed a system that will accomplish this. In all tests, our material outperformed soluble antigen. The encapsulation of antigens in chitosan particles enhanced uptake, activation and presentation by antigen-presenting cells."

The researchers' study was published in the journal Biomaterials.

Vaccine development over the past several decades has shifted toward antigens, which are toxins or other foreign substances that induce an immune response, specifically the production of antibodies. Before this shift, vaccine development had focused on developing whole pathogens, which are bacteria and viruses that cause minor versions of diseases for the purpose of immune response.

With this goal, medical researchers have focused on encapsulating polypeptide antigens in nano- and micro-particles as a strategy to enhance immune response. Packaging antigens in these particles has several advantages. The particles prevent antigen degradation, facilitate ingestion of chemical agents into antigen-presenting cells and can be engineered to carry adjuvants, which are substances in addition to the primary antigen or drug.

One particle material that Zaharoff and other researchers have focused on is chitosan, which is a natural polysaccharide derived primarily from the exoskeletons of crustaceans. Chitosan-based vaccine delivery systems have many advantages, Zaharoff said. The particles are easy to produce, and polypeptides can be encapsulated during particle formation or absorbed into particle surfaces after formation.

Most importantly, chitosan's muco-adhesiveness and ability to loosen gaps between layers of tissue make it an excellent vehicle for delivering vaccine agents.

For their study, Koppolu and Zaharoff focused solely on the function of so-called antigen-presenting cells -macrophages and dendritic cells -- which play a critical role in the production of antibodies that fight bacteria, viruses and other foreign substances.

Macrophage cells are phagocytic, meaning they are capable of engulfing and absorbing bacteria and other small cells and particles. Macrophage cells exist in stationary form in tissues or as a mobile white blood cell, especially at sites of infection. Dendritic cells are other types of immune cells that process antigen material. They are short, branch-like extensions of nerve cells.

The researchers' in vitro experiments demonstrated that antigens encapsulated in chitosan enhanced activation of antigen-presenting cells. The combined material also increased the release of cytokines -- proteins that produce an immune response -- and caused a proliferation of antigen-specific T cells, or lymphocytes, which also actively participate in immune response. The researchers discovered that uptake of antigen encapsulated in chitosan by dendritic cells and macrophages depended on particle size, antigen concentration and exposure time.

Zaharoff has investigated chitosan for several years, going back to his time (2004-2008) at the National Cancer Institute's Laboratory of Tumor Immunology and Biology. In 2009, after coming to the University of Arkansas and setting up the Laboratory of Vaccine and Immunotherapy Delivery, Zaharoff presented results of a major study of the effects of chitosan combined with Interleukin-12, a powerful cytokine.

The combined material eradicated bladder tumors in mice. Zaharoff is currently in discussions with clinical investigators at the University of Arkansas for Medical Sciences to translate the bladder cancer immunotherapy into human trials.

Zaharoff is holder of the Twenty-First Century Professorship in Biomedical Engineering in the College of Engineering.


Story Source:

The above story is based on materials provided by University of Arkansas, Fayetteville. Note: Materials may be edited for content and length.


Journal Reference:

  1. Bhanuprasanth Koppolu, David A. Zaharoff. The effect of antigen encapsulation in chitosan particles on uptake, activation andpresentation by antigen presenting cells. Biomaterials, 2013; 34 (9): 2359 DOI: 10.1016/j.biomaterials.2012.11.066

Cite This Page:

University of Arkansas, Fayetteville. "Antigen-encapsulated chitosan particles improve immune response." ScienceDaily. ScienceDaily, 4 March 2013. <www.sciencedaily.com/releases/2013/03/130304211239.htm>.
University of Arkansas, Fayetteville. (2013, March 4). Antigen-encapsulated chitosan particles improve immune response. ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/2013/03/130304211239.htm
University of Arkansas, Fayetteville. "Antigen-encapsulated chitosan particles improve immune response." ScienceDaily. www.sciencedaily.com/releases/2013/03/130304211239.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins